[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343050-105":59,"doc-detail-343050-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-role-of-cd8-pet-imaging-in-guiding-cancer-immunotherapy","The role of CD8 PET imaging in guiding cancer immunotherapy","","A comprehensive review examines how CD8-positive T cells drive cancer immunotherapy outcomes and why their tumor infiltration and functional status determine treatment heterogeneity. It explains the value of positron emission tomography (PET) for noninvasive molecular monitoring across the whole body, focusing on CD8-focused and biomarker-based PET radiotracers. The review summarizes recent PET tracer advances, their mechanisms, and clinical applications to support precision cancer immunotherapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-role-of-cd8-pet-imaging-in-guiding-cancer-immunotherapy/343050/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-role-of-cd8-pet-imaging-in-guiding-cancer-immunotherapy/343050.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are CD8+ T cells important in cancer immunotherapy?","Question",{"text":112,"@type":113},"CD8+ T cells act as critical immune effector cells. Their tumor infiltration and functional status strongly influence whether patients benefit from immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CD8 PET imaging help address heterogeneity in immunotherapy responses?",{"text":117,"@type":113},"PET radiotracers can noninvasively monitor CD8+ T cells in vivo. By capturing both presence and functional-related signals, imaging supports better stratification of therapeutic response.",{"name":119,"@type":110,"acceptedAnswer":120},"What types of PET radiotracers are discussed for visualizing CD8+ T cells?",{"text":121,"@type":113},"The review groups PET tracers into two categories: those directly targeting CD8 and those indirectly reflecting CD8 functionality or status by targeting related biomarkers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343050,1790215996,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Review  \nPUBLISHED 12 July 2024  \nDOI 10.3389/fimmu.2024.1428541  \nOPEN ACCESS  \nEDITED BY  \nKelsey P. Kubelick,  \nUniversity of Virginia, United States  \nREVIEWED BY Xinpei Deng,  \nSun Yat-sen University Cancer Center (SYSUCC), China  \nAjay Kumar Sharma,  \nJohns Hopkins University, United States  \n*CORRESPONDENCE Yaming Li  \n[ymli2001@163.com](ymli2001@163.com)[ ](ymli2001@163.com)Xuena Li  \n [lixuenacmunm@163.com](lixuenacmunm@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 06 May 2024  \nACCEPTED 27 June 2024  \nPUBLISHED 12 July 2024  \nCITATION  \nZhang J, Du B, Wang Y, Cui Y, Wang S, Zhao Y, Li Y and Li X (2024) The role of CD8 PET imaging in guiding cancer immunotherapy.  \nFront. Immunol. 15:1428541 .  \ndoi: 10.3389/fimmu.2024.1428541  \nCOPYRIGHT  \n© 2024 Zhang, Du, Wang, Cui, Wang, Zhao, Li and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe role of CD8 PET imaging in guiding cancer immunotherapy  \nJiani Zhang †, Bulin Du †, Yuxiang Wang †, Yan Cui, Shu Wang, Yuxuan Zhao, Yaming Li* and Xuena Li*  \nDepartment of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, Liaoning, China  \nCurrently, immunotherapy is being widely used for treating cancers. However, the signiﬁcant heterogeneity in patient responses is a major challenge for its successful application. CD8-positive T cells (CD8+ T cells) play a critical role in immunotherapy. Both their inﬁltration and functional status in tumors contribute to treatment outcomes. Therefore, accurate monitoring of CD8+ T cells, a potential biomarker, may improve therapeutic strategy. Positron emission tomography (PET) is an optimal option which can provide molecular imaging with enhanced speciﬁcity. This review summarizes the mechanism of action of CD8+ T cells in immunotherapy, and highlights the recent advancements in PETbased tracers that can visualize CD8+ T cells and discusses their clinical applications to elucidate their potential role in cancer immunotherapy.  \nKEYWORDS  \nimmunotherapy, CD8 + T cells, PET, clinical application, cancer  \n1 Introduction  \nImmunotherapy has advanced rapidly in the recent past (1–3). Key methods involving immune checkpoint inhibitors (ICIs) and adoptive cell therapy (ACT) have achieved notable success in the clinical management of various cancers (4, 5) . However, durable and effective responses are only observed in a section of patients (6) . Efforts have been made to further optimize immunotherapeutic strategies and several studies have attempted to identify potential biomarkers for improving the therapeutic efﬁcacy (7–9) .  \nCD8+ T lymphocytes, critical immune effector cells, play a vital role in cancer immunotherapy (10, 11) . Studies have shown that improved outcomes correlate positively with CD8+ T cell inﬁltration in several types of tumors (12–14), including melanoma (15), non-small cell lung cancer (NSCLC) (16), breast cancer (17), and cervical cancer (18) . In addition to the quantity of inﬁltration, the functional status of CD8+ T cells within the tumor microenvironment (TME), which is inﬂuenced by interactions with cells and may change with time, also signiﬁcantly affect response to therapy (19, 20) . Both inﬁltration and functional status greatly contribute to the heterogeneity in response to immunotherapy (6, 8, 9) . Therefore, monitoring of CD8+ T cells in vivo is crucial for improving patient understanding and implementation of precision medicine.  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nTumor biopsy, a conventional invasive method, is used in clini","cbCaitMlD6OvhOJX","https://ap.wps.com/l/cbCaitMlD6OvhOJX","pdf",5665025,14,"English","# Introduction\n# Mechanisms of action of CD8 + T cells\n## CD8+ T cells in immunology","[{\"question\":\"Why are CD8+ T cells important in cancer immunotherapy?\",\"answer\":\"CD8+ T cells act as critical immune effector cells. Their tumor infiltration and functional status strongly influence whether patients benefit from immunotherapy.\"},{\"question\":\"How does CD8 PET imaging help address heterogeneity in immunotherapy responses?\",\"answer\":\"PET radiotracers can noninvasively monitor CD8+ T cells in vivo. By capturing both presence and functional-related signals, imaging supports better stratification of therapeutic response.\"},{\"question\":\"What types of PET radiotracers are discussed for visualizing CD8+ T cells?\",\"answer\":\"The review groups PET tracers into two categories: those directly targeting CD8 and those indirectly reflecting CD8 functionality or status by targeting related biomarkers.\"}]","The role of CD8 PET imaging in guiding cancer immunotherapy | PDF",1790049595,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7897ed23fe54d9461ed110a50ffd2696.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdce68809dbd8259c7d1f77e13c545e6.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b0226899274698b005eeed781ea05a2.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0f5b906fbe4ebe460a5e95e88ad0162.webp",980,1385]